Needham & Company LLC Reaffirms Buy Rating for DocGo (NASDAQ:DCGO)

DocGo (NASDAQ:DCGO)‘s stock had its “buy” rating restated by research analysts at Needham & Company LLC in a research report issued to clients and investors on Wednesday, Benzinga reports.

Other analysts have also recently issued research reports about the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of DocGo in a report on Monday, September 14th. Canaccord Genuity Group reissued a “hold” rating and set a $1.00 price target on shares of DocGo in a research report on Tuesday, August 18th. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $2.38.

DocGo Trading Up 6.0%

DCGO traded up $0.02 during trading hours on Wednesday, hitting $0.39. 19,257 shares of the company’s stock were exchanged, compared to its average volume of 880,992. DocGo has a 12-month low of $0.31 and a 12-month high of $1.65. The firm has a market cap of $38.58 million, a P/E ratio of -0.20 and a beta of 0.94. The firm has a 50 day moving average of $0.48 and a 200 day moving average of $0.56.

DocGo (NASDAQ:DCGO) last posted its quarterly earnings results on Monday, August 17th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). DocGo had a negative net margin of 65.29% and a negative return on equity of 40.42%. The company had revenue of $73.42 million during the quarter, compared to analyst estimates of $75.35 million. As a group, research analysts expect that DocGo will post -0.22 EPS for the current fiscal year.

Institutional Trading of DocGo

Several institutional investors and hedge funds have recently bought and sold shares of DCGO. Diversify Advisory Services LLC bought a new stake in shares of DocGo in the 2nd quarter worth approximately $53,000. Isthmus Partners LLC grew its position in DocGo by 14.0% in the first quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock worth $637,000 after buying an additional 124,211 shares during the last quarter. Empowered Funds LLC acquired a new stake in shares of DocGo during the 2nd quarter valued at $79,000. Ieq Capital LLC bought a new stake in shares of DocGo during the 2nd quarter worth $126,000. Finally, Marquette Asset Management LLC bought a new stake in shares of DocGo during the 2nd quarter worth $175,000. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.

The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare.